News | September 27, 2024
Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
Stable profits, low leverage to keep credit profiles comfortable
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Subscribe To Our Newsletter & Stay Updated
